Company: THC
Filing Date: 2025-10-28
Form Type: 10-Q
Source: 0000070318-25-000046
Chunk: 165

Company: TENET HEALTHCARE CORP
Filing Date: 2025-10-28
Form: 10-Q
Item: Part I, Item 8
Chunk 165
---
 September 30, 2025 included $3 million related to the transition of various administrative functions to our GBC, $2 million of contract and lease termination fees, $1 million of employee severance costs, $1 million of legal costs related to the sale of certain businesses and $1 million of other restructuring costs. Impairment charges incurred during the three months ended September 30, 2025 primarily related to the write-down of our investment in an unconsolidated affiliate. During the three months ended September 30, 2024, restructuring charges consisted of $3 million of employee severance costs, $3 million related to the transition of various administrative functions to our GBC, $1 million of legal costs related to the sale of certain businesses and $3 million of other restructuring costs. 

Restructuring charges during the nine months ended September 30, 2025 included $12 million of contract and lease termination fees, $10 million related to the transition of various administrative functions to our GBC, $5 million of employee severance costs, $4 million of legal costs related to the sale of certain businesses and $2 million of other restructuring costs. Impairment charges incurred during the nine months ended September 30, 2025 primarily related to the write-down of our investment in an unconsolidated affiliate. Restructuring charges during the nine months ended September 30, 2024 consisted of $15 million of legal costs related to the sale of certain businesses, $9 million of employee severance costs, $8 million related to the transition of various administrative functions to our GBC and $10 million of other restructuring costs.

Acquisition-related costs consisted entirely of transaction costs for all of the periods in the table above.

Litigation and Investigation Costs (Benefit)

Litigation and investigation costs (benefit) totaled $(11) million and $34 million during the three and nine months ended September 30, 2025, respectively, and $9 million and $18 million for the same periods in 2024, respectively. During the three months ended September 30, 2025, we received proceeds of $28 million from the settlement of two legal matters.

Net Gains on Sales, Consolidation and Deconsolidation of Facilities

We recorded net gains from the sale, consolidation and deconsolidation of facilities totaling $20 million and $4 million